ExodusPoint Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,227
| Closed | -$108K | – | 1972 |
|
|
2024
Q3 | $108K | Buy |
+22,227
| New | +$108K | ﹤0.01% | 1392 |
|
|
2024
Q1 | – | Sell |
-24,036
| Closed | -$335K | – | 1863 |
|
|
2023
Q4 | $335K | Sell |
24,036
-208,584
| -90% | -$2.91M | ﹤0.01% | 1077 |
|
|
2023
Q3 | $3.09M | Buy |
232,620
+42,549
| +22% | +$564K | 0.03% | 492 |
|
|
2023
Q2 | $3.56M | Sell |
190,071
-73,549
| -28% | -$1.38M | 0.03% | 503 |
|
|
2023
Q1 | $3.8M | Buy |
263,620
+196,276
| +291% | +$2.83M | 0.03% | 535 |
|
|
2022
Q4 | $1.3M | Buy |
+67,344
| New | +$1.3M | 0.02% | 818 |
|
|
2022
Q3 | – | Sell |
-114,117
| Closed | -$1.74M | – | 2270 |
|
|
2022
Q2 | $1.74M | Buy |
+114,117
| New | +$1.74M | 0.02% | 798 |
|
|
2021
Q3 | – | Sell |
-5,345
| Closed | -$322K | – | 2588 |
|
|
2021
Q2 | $322K | Buy |
+5,345
| New | +$322K | ﹤0.01% | 1625 |
|